Apimeds Pharma US Ltd (APUS)
Apimeds Pharma US Ltd (APUS) is a common stock listing on the New York Stock Exchange. According to the available company description, the business is focused on digital asset treasury solutions related to bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, in the United Arab Emirates, and it operates as a subsidiary of Inscobee., Inc. The listing is classified as common equity and represents the equity interest in the issuer rather than a fund, preferred security, or debt instrument.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-APUS
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
June 6, 2025
|
—
|
—
|
—
|
28.799 M
|
—
|
—
|
—
|
—
|
—
|
—
|
